{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T03:44:46Z","timestamp":1778125486014,"version":"3.51.4"},"reference-count":10,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2005,8,12]],"date-time":"2005-08-12T00:00:00Z","timestamp":1123804800000},"content-version":"vor","delay-in-days":1959,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["obgyn.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["BJOG"],"published-print":{"date-parts":[[2000,4]]},"abstract":"<jats:p><jats:bold>Objective\n\t\t\t\t\t<\/jats:bold> To consider the organisation cost and effectiveness, of universal, community\u2010based antenatal screening for the haemoglobinopathies, and to estimate the cost\u2010effectiveness of programmes at different levels of prevalence and mix of haemoglobinopathy traits.<\/jats:p><jats:p><jats:bold>Design\n\t\t\t\t\t<\/jats:bold> Retrospective review of laboratory and Sickle Cell and Thalassaemia Centre worksheets with costing of capital equipment, consumables, salaries and overheads, and estimation of costs in a range of circumstances.<\/jats:p><jats:p><jats:bold>Setting\n\t\t\t\t\t<\/jats:bold> A haematology department, including a Sickle Cell and Thalassaemia Centre, providing antenatal and neonatal screening programmes in Inner London.<\/jats:p><jats:p><jats:bold>Participants\n\t\t\t\t\t<\/jats:bold> Two thousand one hundred and one women booking at the antenatal clinic whose samples were referred for screening during 1994.<\/jats:p><jats:p><jats:bold>Main outcome measures and Results\n\t\t\t\t\t<\/jats:bold> In addition to assessing the cost\u2010effectiveness of antenatal haemoglobinopathy screening in a number of settings, the following specific financial information was assembled for the service in Brent: 1. cost of identifying abnormal haemoglobin in mother (\u00a3209); 2. cost of identifying at\u2010risk fetus before confirmation by prenatal diagnosis (\u00a32455); 3. cost of providing genetic information and counselling to mother with abnormal haemoglobin (\u00a3109); 4. programme savings from cases averted (\u00a361,000).<\/jats:p><jats:p><jats:bold>Conclusions\n\t\t\t\t\t<\/jats:bold> Antenatal screening with follow up counselling can be self\u2010financing at most prevalences of haemoglobinopathy traits, with greater savings where a high proportion of the traits are \u03b2 thalas saemia. There is a net financial cost (\u00a31350) only at prevalences below 2.5% of traits if these are mainly for sickle cell disease. Since there are other benefits is it likely that antenatal screening will be considered cost\u2010effective even at quite low levels of trait prevalence.<\/jats:p>","DOI":"10.1111\/j.1471-0528.2000.tb13267.x","type":"journal-article","created":{"date-parts":[[2005,8,12]],"date-time":"2005-08-12T10:41:24Z","timestamp":1123843284000},"page":"486-491","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Organisation and cost\u2010effectiveness of antenatal haemoglobinopathy screening and follow up in a community\u2010based programme"],"prefix":"10.1111","volume":"107","author":[{"given":"Eugenia K.","family":"Cronin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles","family":"Normand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joan S.","family":"Henthorn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vesna","family":"Graham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sally C.","family":"Davies","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2005,8,12]]},"reference":[{"key":"e_1_2_5_2_2","unstructured":"Working Party of the Standing Medical Advisory Committee on Sickle Cell Thalassaernia and other Haemoglobinopathies Report London :HMSO 1993."},{"key":"e_1_2_5_3_2","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1182\/blood.V51.5.971.971","article-title":"Isoelectric focusing in human haemoglobins: its application to screening, to characterization of 70 variants and to study of modified fractions of normal haemoglobins","volume":"51","author":"Bassett P","year":"1978","journal-title":"Blood"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/0005-2795(80)90264-0"},{"issue":"4","key":"e_1_2_5_5_2","first-page":"289","article-title":"Guidelines for investigation of the \u03b1 and \u03b2 thalassaemia traits","volume":"47","author":"Thalassaemia Working Party of the BCSH General Haematology Task Force","year":"1994","journal-title":"J Clin Pathol"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.23.9.781"},{"key":"e_1_2_5_7_2","volume-title":"Practical Haematology","author":"Brozovic M","year":"1995"},{"key":"e_1_2_5_8_2","first-page":"127","volume-title":"Ethnicity and Health: Reviews of Literature and Guidance for Purchasers in the Areas of Cardiovascular Disease, Mental Health and Haemoglobinopathies","author":"Modell B","year":"1996"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199406093302303"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1999.01275.x"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1136\/jms.6.1.3"}],"container-title":["BJOG: An International Journal of Obstetrics &amp; Gynaecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1471-0528.2000.tb13267.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1471-0528.2000.tb13267.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T14:31:45Z","timestamp":1695825105000},"score":1,"resource":{"primary":{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/10.1111\/j.1471-0528.2000.tb13267.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,4]]},"references-count":10,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2000,4]]}},"alternative-id":["10.1111\/j.1471-0528.2000.tb13267.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1471-0528.2000.tb13267.x","archive":["Portico"],"relation":{},"ISSN":["1470-0328","1471-0528"],"issn-type":[{"value":"1470-0328","type":"print"},{"value":"1471-0528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,4]]},"assertion":[{"value":"2005-08-12","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}